Nukkleus Net Income Applicable To Common Shares from 2010 to 2024

NUKK Stock  USD 1.56  0.03  1.96%   
Nukkleus Net Loss yearly trend continues to be quite stable with very little volatility. Net Loss may rise above about -10.1 M this year. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2016-12-31
Previous Quarter
-805.6 K
Current Value
-1.2 M
Quarterly Volatility
1.2 M
 
Covid
Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 172 K, Selling General Administrative of 3.4 M or Selling And Marketing Expenses of 44.1 K, as well as many indicators such as Price To Sales Ratio of 45.05, Ptb Ratio of 51.21 or Capex To Depreciation of 0.0. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
  
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Latest Nukkleus' Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Nukkleus over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Nukkleus' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nukkleus' overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Nukkleus Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(3,140,232)
Coefficient Of Variation(159.34)
Mean Deviation4,255,935
Median(212,187)
Standard Deviation5,003,740
Sample Variance25T
Range11.8M
R-Value(0.78)
Mean Square Error10.7T
R-Squared0.60
Significance0.0007
Slope(868,989)
Total Sum of Squares350.5T

Nukkleus Net Income Applicable To Common Shares History

2024-10.1 M
2023-10.7 M
2021-11.8 M
2020-936.8 K
2019-100.6 K
2018-730.1 K
2017-212.2 K

About Nukkleus Financial Statements

Nukkleus investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Nukkleus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-10.7 M-10.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out the analysis of Nukkleus Correlation against competitors.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.36)
Revenue Per Share
7.024
Quarterly Revenue Growth
(0.97)
Return On Assets
(1.15)
Return On Equity
(7.42)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.